Actinium-225 SKL-35501

N/A

Report date: 2025/11/28 15:14:03

Base Information

Drug NameActinium-225 SKL-35501
Drug Alias Name225-Ac FL-091Actinium-225 FL-091Actinium-225 SKL-35501225-Ac SKL-35501
ClassificationRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Nuclides > Actinium > 225AcRadiation-emitting products > Radionuclide Drug Conjugates
Mechanisms of ActionNeurotensin receptor 1 modulatorsIonising radiation emitters
TargetsNeurotensin receptor 1
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesFull Life Technologies Ltd
China Registration ClassN/A

Develop Information

Active CompaniesFull Life Technologies LtdSK Biopharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A